|
|
|
 > About > About TCTAP |
 |
|
 |
 What TCTAP
can provide |
• |
Review the latest basic and clinical
investigations to guide how to manage optimally
the patients with vascular or structural heart disease. |
• |
Integrate the newest interventional techniques
and devices related to patient care in the coronary,
peripheral and carotid arteries, and structural
heart disease. |
• |
Compare and contrast different approaches to treat
the same type of lesion, and apply an optimal treatment
to various patients in their clinical practice. |
• |
Learn numerous treatment strategies through reviewing
diverse challenging cases submitted from all around
the world and discussing with the world renowned
experts. |
• |
Integrate adjunctive pharmacologic management
in treating patients with cardiovascular disease
and patients underwent intervention therapies. |
|
| Who attends
TCTAP |
• |
Interventional cardiologists |
• |
General cardiologists |
• |
Physicians interested in cardiology and vascular
medicine |
• |
Radiologists |
• |
Basic scientists |
• |
Vascular medicine specialists |
• |
Vascular surgeons |
• |
Cardiac surgeons |
• |
Interventional pediatricians |
• |
Nurses and technologists |
• |
Other health care professionals with special interest
in the interventional vascular therapy and medicine |
|
| Who supports
TCTAP |
TCTAP is sponsored
by CardioVasucular Research Foundation (CVRF) and Asan
Medical Center (Seoul, Korea) and partially funded by
educational grants from commercial supporters.
The CardioVascular Research Foundation wishes to extend
special appreciation to Clinical Research Center for Ischemic
Heart Disease, The Korea Ministry of Health and Welfare
in Korea for their continued support to our programs. |
|
|
|
|
|
|
|
|
